astrazeneca
Shares in AstraZeneca were slightly higher on Thursday despite an update on the European Medicines Agency's website on Wednesday stating the regulator said that the approval for AstraZeneca's Vaxzevria had been withdrawn “at the request of the marketing authorisation holder.” AstraZeneca's Covid-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine's safety, when dozens of countries suspended the vaccine's use after unusual but rare blood clots were detected in a small number of immunised people. The EU regulator concluded AstraZe...
Euronews (English)
The pharma giant AstraZeneca has requested that the European authorisation for its Covid-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s Covid-19 vaccine was first given the nod by the EMA in January 2021. Within weeks, however, concerns grew about the vaccine’s safety, when dozens of countries suspended the vaccine’s use after unusual but rare blood clots were ...
Euronews (English)
Pharmaceutical giant AstraZeneca reported its first quarter 2024 earnings on Thursday, seeing extremely robust earnings per share (EPS) and revenue growth. This was mainly due to continuously growing partner drug sales, as well as increasing demand for the company’s best-selling medicines. Total revenue soared 19% to $12,679 million (€11,818.1 million) year-on-year, primarily boosted by an 18% growth in product sales. Total revenue for oncology jumped 26%, with respiratory and immunology revenue rising 17% and cardiovascular, renal and metabolism revenue inching up 23%. Rare disease revenue ad...
Euronews (English)
The chief executive of pharmaceutical giant AstraZeneca could earn up to £18.7 million (€21.9 million) this year after shareholders approved a motion to increase his pay. Of the shareholders who voted on Thursday, around 64% were in favour of the decision, and 36% were against. Pascal Soriot’s base salary sits at around £1.5 million (€1.76), but he is now able to earn annual incentive payments worth up to 850% of this rate if he hits long-term targets. This compares to his previous incentive allowance of 650%. Since Thursday's vote, Soriot’s annual bonus could also increase to a maximum of 300...
Euronews (English)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら